Skip to main content

Advertisement

Table 2 Outcomes of treatment in two treatment groups

From: Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial

Efficacy measurement End of 3 months End of 6 months
CYC MMF p-value CYC MMF p-value
Primary End point 10 (47.6%) 7 (33.3%) 0.454 4 (19.0%) 6 (28.6%) 0.572
Secondary end point 6 (28.6%) 10 (47.6%) 14 (66.7%) 14 (66.7%)
No Response 5 (23.8%) 4 (19.0%) 3 (14.3%) 1 (4.8%)